Skip to main content

Table 3 Characteristics of HIV infection of HIV/AIDS patients treated with ART in Guangxi between 2003 and 2019

From: Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy

Variables Total (%) (n = 1860) HR (%)
(n = 218)
non-HR (%) (n = 1642) χ2/Z P
Transmission route     10.158 0.038
Heterosexual 1438 (77.31) 176 (80.73) 1262 (76.86)   
Intravenous drug use or blood exchange 53 (2.85) 11 (5.05) 42 (2.56)   
Homosexual 308 (16.56) 24 (11.01) 284 (17.30)   
Vertical 7 (0.38) 0 (0.00) 7 (0.43)   
Unknown 54 (2.90) 7 (3.21) 47 (2.86)   
Mtb infection in the recent year     5.007 0.082
Yes 164 (8.82) 28 (12.84) 136 (8.28)   
No 1680 (90.32) 188 (86.24) 1492 (90.86)   
Unknown 16 (0.86) 2 (0.92) 14 (0.85)   
OIs in the recent 3 months     15.511 <  0.001
Yes 587 (31.56) 94 (43.12) 493 (30.02)   
No 1244 (66.88) 122 (55.96) 1122 (68.33)   
Unknown 29 (1.56) 2 (0.92) 27 (1.64)   
AIDS-related symptoms     0.532 0.466
Yes 252 (13.55) 33 (15.14) 219 (13.34)   
No 1608 (86.45) 185 (84.86) 1423 (86.66)   
WHO clinical stage     10.499 0.015
I 1068 (57.42) 103 (47.25) 965 (58.77)   
II 202 (10.86) 29 (13.30) 173 (10.54)   
III 218 (11.72) 31 (14.22) 187 (11.39)   
IV 372 (20.00) 55 (25.23) 317 (19.31)   
CD4+ T-cell count (cells/ml) 211 (58, 329) 156 (33, 294) 220 (62.5, 333) −3.604 < 0.001
Viral Load (Log10 copies/ml) (Median, IQR) 4.89 (4.37, 5.38) 5.08 (4.38, 5.60) 4.85 (4.31, 5.35) −3.467 0.001
Cotrimoxazole use before baseline     1.499 0.221
Yes 573 (30.81) 75 (34.40) 498 (30.33)   
No 1287 (69.19) 143 (65.60) 1144 (69.67)   
Total 1860 (100.00) 218 (11.72) 1642 (88.28)